Scientists optimized a new method to create the synthetic neurons, which they used to investigate a core enzyme involved in the synthesis of purines - a component of DNA that is involved in many other cellular and metabolic processes - and how the enzyme might change during infection by herpes simplex virus.
Biologists have developed a method for rapidly screening hundreds of thousands of potential drugs for fighting infections, an innovation that holds promise for combating the growing scourge of antibiotic-resistant bacteria. The method involves engineering bacteria to produce and test molecules that are potentially toxic to themselves.
Scientists have developed so-called secondary nanobodies that can replace the most-used antibodies and may drastically reduce the number of animals in antibody production. This is possible because the secondary nanobodies can be produced in large scale by bacteria.